Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Undergraduate Diversity Collaborative seeks spot in Student Executive Council
- Recycle plastic bags at Relay For Life
- Yale scholar to present lecture April 20 on portrayal of Islam in U.S. media
- Next Women Faculty Connect meeting to address questions about mentorship
- Learn how to make philanthropy a lifelong commitment at final Conversations in Philanthropy session